Am­gen and As­traZeneca said on Fri­day that their asth­ma drug Tezspire re­duced nasal con­ges­tion and the size of nasal ...

AstraZeneca and Amgen's drug could have a new use after positive Phase 3 study results. Elsewhere, Jazz set new plans for a ...

AstraZeneca and Amgen's Phase 3 trial data shows Tezspire significantly reduces nasal polyps and congestion in patients with chronic rhinosinusitis with nasal polyps.

Expert says, that by recognising the connection between seasonal changes, allergies, and sinus health, individuals can take ...

Full results from the trial will be presented at an upcoming medical meeting. Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps ...

A sinus infection, also known as sinusitis, occurs when the air cavities around your nasal passages become inflamed and ...

A study published in Frontiers in Medicine reveals that chronic rhinosinusitis with and without nasal polyps is closely correlated with asthma.A study was done to investigate the ...

If nasal polyps grow large enough or multiply, they can block airflow and drainage in the nasal passages, potentially leading ...

Sinus infections can indeed be troubling and disruptive, resulting in symptoms such as headaches, congestion and discomfort in the face that can hinder your everyday activities. Although several ...

Many companies are adopting a subscription business model. Why? Recurring revenue is a more sustainable path to business growth than new customer acquisition. Business owners can make more informed ...

Chronic kidney failure, or end-stage kidney disease (ESKD), occurs when the kidneys no longer function effectively and cannot filter waste and extra fluid from the body. It is the fifth and final ...

Related stories A costly decision Linsey Fagan, a senior talent strategy advisor at Indeed, told BI that most of the recurring layoffs were in tech. That's likely because many companies in the ...